These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25414401)

  • 1. Response to comment on Balkau et al. Factors associated with weight gain in people with type 2 diabetes starting on insulin. Diabetes Care 2014;37:2108-2113.
    Balkau B; Home PD; Vincent M; Marre M; Freemantle N
    Diabetes Care; 2014 Dec; 37(12):e266. PubMed ID: 25414401
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Balkau et al. Factors associated with weight gain in people with type 2 diabetes starting on insulin. Diabetes Care 2014;37:2108-2113.
    Finer N
    Diabetes Care; 2014 Dec; 37(12):e265. PubMed ID: 25414400
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors associated with weight gain in people with type 2 diabetes starting on insulin.
    Balkau B; Home PD; Vincent M; Marre M; Freemantle N
    Diabetes Care; 2014 Aug; 37(8):2108-13. PubMed ID: 24824546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074.
    Hempe JM; Liu S; Myers L; McCarter RJ; Buse JB; Fonseca V
    Diabetes Care; 2015 Oct; 38(10):e172-3. PubMed ID: 26404938
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074.
    Riddle MC; Gerstein HC
    Diabetes Care; 2015 Oct; 38(10):e170-1. PubMed ID: 26404937
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evidence based therapy with insulin in diabetic patients].
    Jermendy G
    Orv Hetil; 2005 Feb; 146(8):341-52. PubMed ID: 15803885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In support of an early intensive treatment of type 2 diabetes and not necessarily of early polypharmacy.
    Czupryniak L; Szymańska-Garbacz E; Pawłowski M; Saryusz-Wolska M; Loba J
    Diabetes Obes Metab; 2011 May; 13(5):474-5. PubMed ID: 22017762
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes and weight management.
    Lau DC
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S24-30. PubMed ID: 20394888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-insulin-dependent diabetes mellitus.
    Blackard WG
    Curr Ther Endocrinol Metab; 1994; 5():395-9. PubMed ID: 7704761
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease.
    Uruska A; Araszkiewicz A; Zozulinska-Ziolkiewicz D; Uruski P; Wierusz-Wysocka B
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):478-84. PubMed ID: 20373280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic control and vascular complications in type 2 diabetes: new observations and clinical significance.
    Lebovitz HE
    J Indian Med Assoc; 2008 Nov; 106(11):724-6. PubMed ID: 19368098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones, insulin resistance and obesity: Finding a balance.
    Wilding J
    Int J Clin Pract; 2006 Oct; 60(10):1272-80. PubMed ID: 16981971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations from an expert group: treatment of non-insulin-dependent diabetes mellitus].
    Lakartidningen; 1990 Mar; 87(11):865-9. PubMed ID: 2179656
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins and diabetes.
    Hitman GA
    Diabet Med; 2014 Jun; 31(6):639. PubMed ID: 24835891
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on Khunti et al. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes care 2015;38:316-322.
    Giménez M; Amor AJ; Quirós C; Conget I
    Diabetes Care; 2015 Jun; 38(6):e91. PubMed ID: 25998305
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of insulin delivery devices in diabetes care.
    Garg SK
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes control without weight gain.
    Health News; 1999 Apr; 5(5):6. PubMed ID: 10214130
    [No Abstract]   [Full Text] [Related]  

  • 18. Intensive glucose-lowering results in increased cardiovascular mortality in younger but not older individuals with type 2 diabetes.
    Giorgino F
    Evid Based Med; 2014 Dec; 19(6):210. PubMed ID: 25028606
    [No Abstract]   [Full Text] [Related]  

  • 19. [Considerations on diabetic angiopathies. Relations to hypoglycemic treatments].
    Lubetzki J
    Nouv Presse Med; 1972 Mar; 1(11):715-8. PubMed ID: 5022249
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypoglycemic medications and vascular complications of diabetes mellitus. Current controversy].
    Lubetzki J
    Rev Prat; 1976 Oct; 26(45):3173-83. PubMed ID: 981918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.